Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-18-000038

Options or other derivatives

  • President and CEO acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fardis Maria · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-02-09 Grant or award : show line 1 in the form Stock Option (right to buy) +500,000 $16.80 2028-02-08 500,000 500,000 D
Loading xslF345X03/primary_doc.xml…